{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:50:59Z","timestamp":1773024659695,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"publisher","award":["n.a."],"award-info":[{"award-number":["n.a."]}],"id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Introduction: As thyroid hormones modulate proliferative pathways it is surmised that they can be associated with cancer development. Since the potential association of gastroesophageal cancer and thyroid disorders has not been addressed so far, the aim of this study was to investigate the association of thyroid hormone parameters with the outcome of these patients, so novel prognostic and even potentially therapeutic markers can be defined. Material and Methods: Clinical and endocrinological parameters of patients with resectable gastroesophageal cancer treated between 1990 and 2018 at the Vienna General Hospital, Austria, including history of endocrinological disorders and laboratory analyses of thyroid hormones at first cancer diagnosis were investigated and correlated with the overall survival (OS). Results: In a total of 865 patients, a tendency towards prolonged OS in hypothyroid patients (euthyroid, n = 647: median OS 29.7 months; hyperthyroid, n = 50: 23.1 months; hypothyroid, n = 70: 47.9 months; p = 0.069) as well as a significant positive correlation of thyroid hormone replacement therapy with the OS was observed (without, n = 53: median OS 30.6 months; with, n = 67: 51.3 months; p = 0.017). Furthermore, triiodothyronine (T3) levels were also associated with the OS (median OS within the limit of normal: 23.4, above: 32.4, below: 9.6 months; p = 0.045). Conclusions: Thyroid disorders and their therapeutic interventions might be associated with the OS in patients with resectable gastroesophageal cancer. As data on the correlation of these parameters is scarce, this study proposes an important impulse for further analyses concerning the association of thyroid hormones with the outcome in patients with gastroesophageal tumors.<\/jats:p>","DOI":"10.3390\/cancers13205050","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:19:32Z","timestamp":1633900772000},"page":"5050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis"],"prefix":"10.3390","volume":"13","author":[{"given":"Hannah C.","family":"Puhr","sequence":"first","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten J.","family":"Reiter","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Mahrouk","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Saliternig","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6537-3874","authenticated-orcid":false,"given":"Maximilian J.","family":"Mair","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-8301","authenticated-orcid":false,"given":"Ariane","family":"Steindl","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7119-8454","authenticated-orcid":false,"given":"Matthias","family":"Paireder","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Department of Surgery, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Asari","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Department of Surgery, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian F.","family":"Schoppmann","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Department of Surgery, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna S.","family":"Berghoff","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-0873","authenticated-orcid":false,"given":"Ayseg\u00fcl","family":"Ilhan-Mutlu","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","first-page":"1","article-title":"Prognostic Models for Predicting Overall Survival in Patients with Primary Gastric Cancer: A Systematic Review","volume":"2019","author":"Feng","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MED.0b013e32833d9710","article-title":"Thyroid hormones and cancer: Clinical studies of hypothyroidism in oncology","volume":"17","author":"Hercbergs","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1074\/mcp.M800195-MCP200","article-title":"Mechanism of cancer cell adaptation to metabolic stress: Proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway","volume":"8","author":"Liu","year":"2009","journal-title":"Mol Cell Proteom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/ERC-12-0219","article-title":"Thyroid hormone, thyroid hormone receptors, and cancer: A clinical perspective","volume":"20","author":"Moeller","year":"2013","journal-title":"Endocrine-Related Cancer."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-019-00374-1","article-title":"Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis","volume":"11","author":"Puhr","year":"2019","journal-title":"Horm. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014When and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10456-014-9418-5","article-title":"Modulation of angiogenesis by thyroid hormone and hormone analogues: Implications for cancer management","volume":"17","author":"Mousa","year":"2014","journal-title":"Angiogenesis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Edgren","year":"2012","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/gut.2009.190827","article-title":"Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: Are the effects modified by smoking, NSAIDs or acid suppressants?","volume":"59","author":"Pandeya","year":"2009","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.suc.2012.07.008","article-title":"Epidemiology of Esophageal Cancer","volume":"92","author":"Wheeler","year":"2012","journal-title":"Surg. Clin. N. Am."},{"key":"ref_14","first-page":"85","article-title":"Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma","volume":"4","author":"Vaughan","year":"1995","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_15","first-page":"153","article-title":"On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases","volume":"15","author":"Beatson","year":"1896","journal-title":"Trans. Medico-Chirurgical Soc. Edinb."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.20881","article-title":"Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma","volume":"103","author":"Cristofanilli","year":"2005","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2020.05.011","article-title":"Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer","volume":"135","author":"Berghoff","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/bjc.1993.378","article-title":"Enhancement by thyroxine of gastric carcinogenesis induced by N-methyl-N\u2019-nitro-N-nitrosoguanidine in Wistar rats","volume":"68","author":"Iishi","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1089\/thy.2019.0413","article-title":"Integrin \u03b1v\u03b23-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis","volume":"29","author":"Schmohl","year":"2019","journal-title":"Thyroid"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liu, Y.-C., Yeh, C.-T., and Lin, K.-H. (2019). Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20204986"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1200\/JCO.2020.38.15_suppl.4502","article-title":"Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES\/FLOT7): Results of the phase II-portion\u2014A multicenter, randomized phase II\/III trial of the German AIO and Italian GOIM","volume":"38","author":"Hofheinz","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1200\/JCO.2020.38.15_suppl.4543","article-title":"Impact of frontline doublet versus triplet therapy on clinical outcomes: Exploratory analysis from the RAINBOW study","volume":"38","author":"Klempner","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2010.11.011","article-title":"Thyroid hormone as a regulator of tumor induced angiogenesis","volume":"301","author":"Pinto","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12929-021-00719-5","article-title":"Role of thyroid hormone-integrin \u03b1v\u03b23-signal and therapeutic strategies in colorectal cancers","volume":"28","author":"Yang","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br. Med Bull."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1186\/1756-6614-6-S2-A48","article-title":"Molecular mechanism of thyroid hormone action in carcinogenesis","volume":"6","year":"2013","journal-title":"Thyroid. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/147323000503300210","article-title":"Gastric Carcinoma and Thyroid Status","volume":"33","author":"Kandemir","year":"2005","journal-title":"J. Int. Med. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2458-9-132","article-title":"Trends in thyroid hormone prescribing and consumption in the UK","volume":"9","author":"Mitchell","year":"2009","journal-title":"BMC Public Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/er.2013-1083","article-title":"Treatment With Thyroid Hormone","volume":"35","author":"Biondi","year":"2014","journal-title":"Endocr. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14310\/horm.2002.11120","article-title":"The serum triiodothyronine to thyroxine (T3\/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy","volume":"3","author":"Mortoglou","year":"2004","journal-title":"Hormones"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2019.00059","article-title":"Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies","volume":"10","author":"Krashin","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Nappi, A., De Stefano, M.A., Dentice, M., and Salvatore, D. (2021). Deiodinases and Cancer. Endocrinology, 162.","DOI":"10.1210\/endocr\/bqab016"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI29812","article-title":"Deiodinases: Implications of the local control of thyroid hormone action","volume":"116","author":"Bianco","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/07435800.2019.1600536","article-title":"Action of Reverse T3 on Cancer Cells","volume":"44","author":"Lin","year":"2019","journal-title":"Endocr. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jnci\/djq042","article-title":"A Case\u2013Control Study of Levothyroxine and the Risk of Colorectal Cancer","volume":"102","author":"Rennert","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00404-018-4837-y","article-title":"Levothyroxine use and the risk of breast cancer: A nation-wide population-based case\u2013control study","volume":"298","author":"Wu","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-536","article-title":"T3 levels in relation to prognostic factors in breast cancer: A population-based prospective cohort study","volume":"14","author":"Tosovic","year":"2014","journal-title":"BMC Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3892\/ijo.2016.3668","article-title":"Triiodothyronine regulates cell growth and survival in renal cell cancer","volume":"49","author":"Czarnecka","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.31327","article-title":"Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia","volume":"143","author":"Gao","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/jc.2017-01939","article-title":"Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin \u03b1v\u03b23","volume":"103","author":"Hercbergs","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:58Z","timestamp":1760166658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":40,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cancers13205050"],"URL":"https:\/\/doi.org\/10.3390\/cancers13205050","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-469310\/v1","asserted-by":"object"}]},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]}}}